Bionano Genomics Inc (NASDAQ: BNGO) is -35.68% lower on its value in year-to-date trading and has touched a low of $0.17 and a high of $1.40 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BNGO stock was last observed hovering at around $0.18 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $0.19, the stock is -18.76% and -21.51% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.23 million and changing 3.00% at the moment leaves the stock -65.65% off its SMA200. BNGO registered -85.16% loss for a year compared to 6-month loss of -70.30%. The firm has a 50-day simple moving average (SMA 50) of $0.2392 and a 200-day simple moving average (SMA200) of $0.5441.
The stock witnessed a -11.67% gain in the last 1 month and extending the period to 3 months gives it a -44.34%, and is -9.60% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.26% over the week and 19.13% over the month.
Bionano Genomics Inc (BNGO) has around 344 employees, a market worth around $25.94M and $33.33M in sales. Profit margin for the company is -407.34%. Distance from 52-week low is 6.89% and -86.75% from its 52-week high. The company has generated returns on investments over the last 12 months (-250.76%).
with sales reaching $6.3M over the same period.The EPS is expected to grow by 77.20% this year, but quarterly earnings will post -19.97% year-over-year. Quarterly sales are estimated to shrink -41.24% in year-over-year returns.
64.0 institutions hold shares in Bionano Genomics Inc (BNGO), with institutional investors hold 12.83% of the company’s shares. The shares outstanding are 139.82M, and float is at 139.11M with Short Float at 12.69%. Institutions hold 12.81% of the Float.
